DOWNLOAD SILCO PHARMACEUTICALS LIMITED LOTTERY RESULT HERE:
Stock Broker / Merchant Bank Code
Non-Residence Bangladeshi (NRB)
Eligible Investors (Pro- Rata Allotment)
Update: Silco Pharmaceuticals Limited IPO subscription will start from 7 March’19 to 19 March’19
The Bangladesh Securities Exchange Commission (BSEC) approved IPO Silco Pharmaceuticals Limited on Wednesday, 19 December 2018 at their 669 nos Board Meeting. Presided by BSEC Chairman Prof. Dr. M Khairul Hossain to raise Tk. 30 crore by offloading around 3 crore shares at a price of Tk. 10 each share. Company Information, IPO Application Form, Prospectus & Result is given below:
Company Name: Silco Pharmaceuticals Limited (SPL)
Incorporation: The company was incorporated in 25 January 1995 as a public limited company.
Commercial Operation: According to the certificate of Commencement the date of commercial operation is 25 January, 1995 but the Company received the drug manufacturing license on 29 October, 2003 and the commercial operation has started on 30 October, 2003.
Authorized Capital: Tk. 1,050,000,000 divided into 105,000,000 ordinary shares of Tk. 10.00 each
Paid Up Capital (Before IPO): Tk. 643,700,000 divided into 64,370,000 ordinary shares of Tk. 10.00 each
Paid Up Capital (After IPO): Tk. 300,000,000 divided into 30,000,000 ordinary shares of Tk. 10.00 each
Management Body: 1) Mrs. Naim Fatema, Chairman
2) Dr. Md. Badrul Haque Rukan, Managing Director
3) Dr. Md. Azizur Rahman, Director
4) Dr. Shahana Ferdous Chowdhury, Director
5) Dr. Gulshan-E-Jahan, Director
6) Prof. Dr. Md. Harunur Rashid, Director
7) Dr. Mahmudul Majid Chowdhury, Director
8) Prof. Dr. Faisal Ahmed, Director
9) Prof. Dr. Md. Abul Ahbab, Independent Director
10) Prof. Dr. Md. Rezaul Karim, Independent Director
11) Dr. Iqbal Hossain Chowdhury, Independent Director
NAME OF SUBSIDIARIES:
Registered & Corporate Office :
Email –[email protected]
SILCO PHARMACEUTICALS LIMITED EPS & NAV:
As per the financial statement for the year ended on June 30, 2017, the company’s net asset value (NAV) stood at Tk 25.41 per share, whereas the weighted average EPS was Tk 1.46.
City Bank Capital Resources Ltd, EBL Investments Ltd, and Citizen Securities and Investment Ltd will act as the issue manager for the IPO process.
WHY PUBLIC OFFERING:
Bangladesh Securities Exchange Commission (BSEC) approved IPO of above Co. on 19 December 2018. The companies will raise a fund worth Tk. 30.00 million for the purpose of construction of factory building, acquisition of plant & machinery, purchase of delivery van & for IPO expenses.
NOS. OF SHARE OFFER : 30,000,000
TOTAL VALUE OF IPO: Tk. 300,000,000/=
FACE VALUE: Tk. 10/=
PREMIUM VALUE: Tk. Nil
MARKET LOT: 500
MINIMUM LOT VALUE: Tk.5000/=
SHARE ALLOTMENT: 32% for General Public=19,200 lot and 8% for Affected Investors=4,800 lot, 40% for Eligible Investor (EI) =24,000 lot, 10% for NRB = 6,000 lot and 10% for Mutual Fund =6,000 lot.
** The Company will collect IPO money through BSEC new rules and the new rule is “BROKER HOUSE SHOULD COLLECT IPO MONEY ONLY”.
The Company’s Subscription will start from 7 March 2019 to 19 March 2019.
DOWNLOAD IPO FORM HERE:
SILCO PHARMACEUTICALS LTD.: PROSPECTUS
THANK YOU FOR VISITING MAXBANGLA.COM.